Ibrahim M. Shokry, BVSc, MVSc, PhD
Dr. Shokry has been with Ross University School of Veterinary Medicine since 1989. In addition to his teaching responsibilities, Dr. Shokry advises the student Integrative Veterinary Medicine Club (IVMC).
He completed a post-doctoral research fellowship with the Department of Pharmacology, Guy’s Hospital Medical School in London, U.K. In addition, he was a visiting scientist at Iowa State University, College of Veterinary Medicine, and has been appointed as a research affiliate professor at Charles E. Schmidt College of Medicine, FAU in Florida.
BVSC Veterinary Medicine, Cairo University
MVSC Pharmacology, Cairo University
PHD Pharmacology, Cairo University
Distinguished Teaching Award several times
Dean's Appreciation Award
Student's Appreciation Award
Faculty Appreciation Award several times
Ross Team Award-Male Professor of the Year
Carl Norden-Pfizer Distinguished Teacher Award
DeVry Service Excellence Medal for demonstration of TEACH values
DeVry Education Group Long-Term Incentive (LTI) Award.
Phi Zeta membership, 2019
30 Years of Service Award, May 22nd 2019
Dedication of the Toxic Plant Garden to be named Dr. Ibrahim M. Shokry Toxic Plant Garden, Ross University School of Veterinary Medicine, May 22nd 2019
Shokry IM and Moffet J, How toxic plants are taught at Ross University School of Veterinary Medicine, St. Kitts, West Indies (poster). VetEd 2014 Symposium Proceedings, Bristol, UK, July 10-11, 2014 page 23
Tao R, Shokry IM, Callanan JJ, Adams HD, and Ma Z, 2015, Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats. Psychopharmacology 232:1245-1260
Shokry IM, Callanan JJ, Sousa J, Tao R, 2015, Rapid in situ hybridization using oligonucleotide probes on paraformaldehyde-prefixed brain of rats with serotonin syndrome. J Visualized Exp
Shokry IM, Callanan JJ, Sousa J, Tao R. Why direct intracerebroventricular injection of 3,4-methylenedioxymethamphetamine (ecstasy) failed to produce serotonin syndrome in animal models? European Neuropsychopharmacology, Vol. 25; S246-S247; Published in issue September 2015
Shokry IM, Callanan JJ, Sousa J, Tao R: New insights on different response of MDMA-elicited serotonin syndrome to systemic and intracranial administration in the rat brain. PloS One 2016 May 18; 11 (5)
Shokry IM, Maqueira A, Callanan JJ, Shields C, Clayton C, Tao R. Effects of synthetic cathinones (‘bath salts’) on rat behavior. European Neuropsychopharmacology, Vol. 26, S230, October 2016
Tao R, Shokry, IM, Callanan JJ. Environment underlying Ecstasy-induced serotonin syndrome. Annals of Forensic Research and Analysis. 4(1): 1039, 2017
Shokry IM, Callanan JJ, Tao R. D1 receptors, but not D2, mediate the locomotor activity and behavioral sensitization caused by 3,4-methylenedioxypyrovalerone (MDPV) in rats. European Neuropsychopharmacology. Vol 27, Supplement 4. October 2017, Page S642
Shokry IM, DeSuza K, Callanan JJ, Shim G, Ma Z, Tao R (2018). Individuals with hyperthyroidism are more susceptible to having a serious serotonin syndrome following MDMA (Ecstasy) administration in rats. Ann Forensic Res Anal 5(1):1052.
Shokry I.M., Callanan J.J., Tao, R. Cortical dopamine is essential for the hallucinogenic effect of 3,4-methylenedioxypyrovalerone (MDPV) demonstrated by enhanced EEG activity in rats. European European Neuropsychopharmacology, Volume 29, Supplement 1 (2019) pp. S1-S630
Shokry IM, Sinha V, Da Silva G, Park SB, Callanan JJ, Tao R. Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats. Exp Neurolo. (2019) 313:26-36
Shokry IM, Shields CJ, Callanan JJ, Ma Z, Tao R. Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats. BMC Pharmacol Toxicol. 2019 Aug 5; 20(1):47 https://www.ncbi.nlm.nih.gov/pubmed/31383036 https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-019-0326-60.
Minnerly C, Bressler SL, Shokry IM, Tao R. Estimating mental health conditions of patients with opioid use disorder. Journal of Addiction, Volume 2019, Article ID 8586153, 15 pages, 2019 https://www.hindawi.com/journals/jad/2019/8586153/
Molecular pharmacology underlying susceptibility to serotonin poisoning
Synthetic cathinones (Bath salts)-induced psychosis
Featured in International Media
Developed the Toxic Plant Garden (Ross University School of Veterinary Medicine)
Developed the Toxic Plants Website (Ross University School of Veterinary Medicine)
Developed the Toxic Plant Museum